Gail
New Poster
Offline
Posts: 2
Dedham, USA, MA, Massachusetts
Gender:
|
Thanks for the feedback, Shari!
Great question, Greg! In answer to your question......
As I mentioned before, it is wise for MMD patients to avoid increasing SEROTONIN in the neural synapse, as it causes cerebral vasoconstriction. SSRI medications INCREASE serotonin by preventing its reuptake into cells.
Here is an outline of the mechanisms of the newer antidepressants, which I categorize as "SSRIs" and "Others." The "Others" either do (Effexor, Serzone) or do not (Wellbutrin) increase serotonin in the neural synapse.
1) SSRIs: (selective SEROTONIN reuptake inhibitors) include Fluoxetine (Prozac), Paroxetine (Paxil), Sertraline (Zoloft), Fluvoxamine (Luvox), Citalopram (Celexa), Escitalopram (Lexapro).
"OTHERS:" 2) NSRI (norepinephrine + SEROTONIN reuptake inhib.) = Nefazodone (Serzone)
3) NSDRI (norepinephrine, SEROTONIN, + dopamine reuptake inhibition = Venlafaxine (Effexor)
4) NDRI (norepinephrine + dopamine reuptake inhibition) = Buproprion (Wellbutrin)
Two points: 1) Reuptake inhibition INCREASES the availability of the neurotransmitter at the neural synapse (by preventing reuptake into the neuronal cell). 2) Buproprion is the ONLY antidepressant for which serotonin is NOT involved.
My dear sister just received her diagnosis (FINALLY) this week (age 45, symptomatic x 5 years). I am so glad for this site and look forward to jumping in with pharmacy-related contributions as we travel this road together.
Gail Tsolirides, PharmD
|